Skip to content
AnalystLens

JHX · James Hardie Industries

29 filings

10-K

JHX 10-K Annual Reports

James Hardie Industries - 29 annual reports

Filing record · 2016–202610-K1210-Q28-K402

JHX filed 12 annual reports (10-K), 2 quarterly reports (10-Q) and 402 current reports (8-K) between 2016 and 2026.

  1. FY2025 annual report10-K · May ’25May ’25
  1. 2026

    James Hardie Industries Annual Report, Year Ended Mar 31, 2026

    James Hardie Industries plc (JHX) reported fiscal year 2026 (ended March 31, 2026) net sales of $4,835.8 million, up 25% from $3,877.5 million, driven primarily by the AZEK acquisition, which closed on July 1, 2025 and contributed net sales of $1,065.0 million. Net income fell to $104.0 million from $424.0 million, reflecting lower operating income of $447.6 million (versus $655.9 million), $206.9 million of acquisition-related expenses, $493.5 million of depreciation and amortization including AZEK intangible amortization, a $47.9 million inventory step-up charge, and interest, net of $231.1 million versus $10.3 million a year earlier. Adjusted EBITDA was $1,265.8 million, a 26.2% margin, and Free Cash Flow was $314.1 million. The balance sheet changed substantially. Total assets rose to $13,688.6 million from $5,229.9 million, and gross debt increased to $4,567.2 million from $1,124.0 million, funded by $2,500.0 million of Term Facilities, $1,700.0 million of senior secured notes, and the cash consideration for AZEK. Cash and cash equivalents were $269.2 million at year end, with $994.1 million available under the Revolving Credit Facility. The company paid no dividends and repurchased no shares in the fiscal year, and it expects to retain earnings to reduce debt. Management noted that North America fiber cement sales declined 6% on market weakness, and the company closed its Fontana, California and Summerville, South Carolina plants. The filing also describes the company's status as a US domestic issuer effective April 1, 2026, and several pending securities class actions in the US and Australia, for which no reserve has been recorded. The asbestos liability stood at $1,008.6 million, and the company expects to contribute approximately A$136 million to AICF in fiscal 2027.

    May 19, 2026
  2. 2025

    James Hardie Industries Annual Report, Year Ended Mar 31, 2025

    James Hardie Industries plc reported fiscal year 2025 (year ended 31 March 2025) net sales of US$3,877.5 million, down from US$3,936.3 million in FY24, with operating income of US$655.9 million (versus US$767.4 million) and net income of US$424.0 million (versus US$510.2 million). Diluted EPS was US$0.98 compared with US$1.16. The decline was driven mainly by lower volumes in North America and Asia Pacific, lower North American gross margin, restructuring charges of US$50.3 million tied to closing Philippines operations, US$16.5 million of merger costs, and asbestos-related expenses and adjustments of US$140.5 million. Management reported Adjusted EBIT of US$863 million and Adjusted net income of US$644 million for the year. The most significant pending event is the merger agreement with The AZEK Company Inc., signed in March 2025 for a combination of cash and James Hardie shares, with closing expected in the second half of calendar 2025 subject to AZEK shareholder approval and regulatory clearance. The company secured a bridge commitment of up to US$4.3 billion and expects total debt of approximately US$4.4 billion after closing, compared with US$1.1 billion at 31 March 2025. Management guided that US employee residential end markets will be down in fiscal 2026, with Repair and Remodel expected to decline more than New Construction, while Australia and Europe addressable markets are expected to be flat. Balance sheet and cash flow remained solid, with cash of US$562.7 million, gross debt of US$1,124.0 million, and net cash from operating activities of US$802.8 million. The company repurchased 4.5 million shares for US$149.9 million and expects to pay about A$185 million to the asbestos fund AICF in fiscal 2026. The asbestos liability stood at US$983.6 million at 31 March 2025.

    May 20, 2025
  3. 2024

    James Hardie Industries Annual Report, Year Ended Mar 31, 2024

    James Hardie Industries plc, a world leader in fiber cement building solutions and a market leader in European fiber gypsum products, reported record fiscal year 2024 (year ended 31 March 2024) net sales of US$3.94 billion, up 4% from US$3.78 billion in FY23. Net income was US$510.2 million, essentially flat versus US$512.0 million, as higher asbestos adjustments of US$151.7 million and a US$20.1 million impairment tied to cancelling the Truganina greenfield project offset gains in operating income. Operating income was US$767.4 million, with operating income margin of 19.5%. Diluted EPS was US$1.16 versus US$1.15 the prior year. The filing reports adjusted operating income of US$940.8 million and adjusted net income of US$707.5 million, both non-GAAP measures reconciled in the filing. North America Fiber Cement drove results, with net sales of US$2,891.4 million (up 4%), operating income of US$921.1 million and operating margin of 31.9%, up 4.4 percentage points. Asia Pacific and Europe Building Products showed improvement in margins, while European volumes declined 13% as the housing market contracted. Cash provided by operating activities rose to US$914.2 million from US$607.6 million, capital expenditures were US$449.3 million, and the company repurchased 8.7 million shares for US$271.4 million. Total debt was US$1,129.1 million at year end, against cash of US$365.0 million. Management expects US residential end markets to be down slightly in fiscal 2025 and estimates fiscal 2025 capital expenditures of US$500 million to US$550 million. Key risks disclosed include the asbestos liability of US$989.7 million tied to the AICF funding agreement, an open New Zealand weathertightness case (Cridge) with no reserve recorded, a potential Australian Taxation Office transfer pricing claim of approximately A$110 million, and a securities class action in Australia. The filing states the internal control over financial reporting was effective as of 31 March 2024.

    May 20, 2024
  4. 2023

    James Hardie Industries Annual Report, Year Ended Mar 31, 2023

    James Hardie Industries plc, filing its Annual Report on Form 20-F for the fiscal year ended 31 March 2023, reported record net sales of US$3,777.1 million, up 4% from US$3,614.7 million, driven by Price/Mix growth of 9% partly offset by a 5% volume decrease. Operating income rose 9% to US$741.4 million, helped by a lower asbestos adjustments loss (US$37.0 million versus US$131.7 million), while net income increased 12% to US$512.0 million and diluted EPS was US$1.15 versus US$1.03. Management described a challenging macro environment, with high input costs and significant inflationary pressures weighing on segment results, and the filing notes Europe and Asia Pacific earnings declined. Liquidity and capital allocation shifted during the year. Capital expenditures rose to US$591.3 million from US$257.8 million, including a US$378.4 million global capacity expansion spend, and operating cash flow fell to US$607.6 million from US$757.2 million. Gross debt increased to US$1,066.1 million from US$886.4 million, and the company repurchased 3.8 million shares for US$78.4 million under a program launched in November 2022. Cash and cash equivalents ended at US$113.0 million. Looking ahead, management expects US residential end markets to contract significantly in fiscal 2024 versus fiscal 2023 and estimates fiscal 2024 capital expenditures of approximately US$550 million. The filing also discloses a US$977.1 million asbestos liability tied to the AICF funding agreement, a New Zealand weathertightness litigation matter, and a newly filed Australian securities class action.

    May 16, 2023
  5. 2022

    James Hardie Industries Annual Report, Year Ended Mar 31, 2022

    James Hardie Industries plc's Annual Report on Form 20-F for fiscal year ended 31 March 2022 reports net sales of US$3,614.7 million, up 24% from US$2,908.7 million, with operating income of US$682.6 million, up 44%, and net income of US$459.1 million, up 75%. Diluted earnings per share were US$1.03 versus US$0.59. Growth was driven by Price/Mix growth of 10% and volume growth of 14%, with North America Fiber Cement net sales up 25% and operating income up 27%. Gross margin was broadly flat at 36.3%, while SG&A rose 18% on investment in marketing, innovation and talent. The company stated that US residential end-market growth is expected to continue into fiscal 2023. The balance sheet and cash flow reflect the company's asbestos obligations under the Amended and Restated Final Funding Agreement (AFFA) with the Asbestos Injuries Compensation Fund. The asbestos liability was US$1,143.7 million at 31 March 2022, and US$248.5 million was funded to AICF during the year. Net cash provided by operating activities was US$757.2 million, capital expenditures were US$257.8 million, and dividends paid were US$484.0 million. Cash and cash equivalents were US$125.0 million and gross debt was US$886.4 million. The company plans capital expenditures of US$1.6 billion to US$1.8 billion over the next four years for a global capacity expansion program. Governance matters flagged in the filing include the termination of CEO Dr Jack Truong on 6 January 2022, with Harold Wiens serving as interim CEO and Michael Hammes as Executive Chairman. The Board is expected to be renewed with at least two new non-executive directors and a new CEO during fiscal 2023. The filing also discloses ongoing New Zealand weathertightness litigation, for which no reserve has been recorded, and the Cridge appeal is expected to be decided no sooner than December 2022.

    May 17, 2022
  6. 2021

    James Hardie Industries Annual Report, Year Ended Mar 31, 2021

    James Hardie Industries plc, filing its Annual Report on Form 20-F for the fiscal year ended 31 March 2021, reported net sales of US$2,908.7 million, up 12% from US$2,606.8 million in FY20, with operating income of US$472.8 million (up 38%) and net income of US$262.8 million (up 9%). Diluted earnings per share were US$0.59. Adjusted net income was US$458.0 million and adjusted diluted EPS was US$1.03, both non-GAAP measures reconciled in the filing. Growth was led by North America Fiber Cement, where net sales rose 12% to US$2,040.2 million and operating income margin reached 28.7%. Asia Pacific and Europe Building Products also improved, with Europe net sales rising 10% in US dollars to US$410.3 million. The balance sheet strengthened as gross debt fell from US$1,370.7 million to US$868.3 million after the early redemption of US$400.0 million of 2025 notes. Cash rose to US$208.5 million, and operating cash flow was US$786.9 million, up from US$451.2 million. Management declared a FY2021 special dividend of US$0.70 per share (about US$309.6 million), and said ordinary dividends would be reinstated in FY2022. Capital expenditure was US$110.7 million, and the company expects roughly US$250.0 million annually over the next three fiscal years. The principal investor consideration is the asbestos liability tied to the AFFA funding of AICF. The gross asbestos liability was US$1,135.8 million at 31 March 2021, and asbestos adjustments were a US$143.9 million charge, mainly from foreign exchange, as the AUD/USD rate moved 23%. Annual AICF contributions are expected to be about US$252.6 million in FY2022, equal to 35% of free cash flow. Pending New Zealand weathertightness litigation, including the Cridge case, has no recorded reserve.

    May 18, 2021
  7. 2020

    James Hardie Industries Annual Report, Year Ended Mar 31, 2020

    James Hardie Industries plc reported net sales of $2,606.8 million for fiscal year 2020 (year ended 31 March 2020), up from $2,506.6 million in fiscal 2019, with net income of $241.5 million versus $228.8 million. Gross profit rose to $933.7 million, and the North America Fiber Cement segment was the main driver, with net sales of $1,816.4 million and operating income of $429.3 million. Results were weighed down by asset impairment charges of $84.4 million, mainly tied to the closure of the Summerville, South Carolina plant and the Penrose, New Zealand operations, and by asbestos adjustments of $58.2 million, which included a $128.0 million unfavorable actuarial adjustment recorded in the fourth quarter. The filing's most investor-relevant update is its response to COVID-19. Management suspended dividends until further notice, reduced FY21 capital expenditures to a range of US$80 to US$95 million compared with a historic three-year annual average of approximately US$240 million, and will pay its AICF contributions quarterly instead of in one lump sum. The company stated it is unable to provide outlook or trend information for the coming year. Net debt was $1,210.2 million at 31 March 2020, down from $1,301.6 million, and operating cash flow was $451.2 million. The filing also highlights ongoing exposure to the Asbestos Injuries Compensation Fund through the AFFA, with a gross asbestos liability of US$986.4 million and anticipated FY21 contributions of approximately US$153.3 million, equal to 35% of free cash flow as defined by the AFFA. Management also disclosed a planned Prattville, Alabama greenfield capacity project of 600 mmsf, with an expected commissioning in FY22.

    May 19, 2020
  8. 2019-A

    James Hardie Industries Annual Report (Amendment), Year Ended Mar 31, 2019

    This Amendment No. 1 on Form 20-F/A by James Hardie Industries plc amends the Company's 2019 Form 20-F for the fiscal year ended 31 March 2019, originally filed on 21 May 2019. The amendment does not change financial results. It revises the Controls and Procedures section (Item 15) to add a disclosure that management's assessment of internal control over financial reporting excluded Fermacell, the business acquired on 3 April 2018, as permitted by SEC rules for acquired businesses. The same information was already in Item 3.D of the original filing, and the amendment adds the related attestation report of Ernst & Young LLP along with amended Section 302 and 906 certifications. The Chief Executive Officer and Chief Financial Officer concluded that disclosure controls were effective at a reasonable assurance level as of 31 March 2019. Management concluded that internal control over financial reporting was effective as of 31 March 2019, and Ernst & Young LLP expressed an unqualified opinion on that effectiveness. The excluded Fermacell business accounted for 17.2% of total assets, 37.0% of net assets, 13.3% of revenues and 2.1% of operating income in the consolidated financial statements for the year. Management reported no changes in internal control over financial reporting during the period that materially affected, or were reasonably likely to materially affect, those controls. For investors, the key takeaway is that the amendment is a disclosure-only correction and does not alter the company's reported financial position. The notable detail is the size of the carve-out: Fermacell represents a large share of total and net assets despite contributing a smaller share of revenues and operating income.

    Aug 8, 2019
  9. 2019

    James Hardie Industries Annual Report, Year Ended Mar 31, 2019

    James Hardie Industries plc's 2019 Annual Report on Form 20-F (fiscal year ended 31 March 2019) reports net sales of US$2,506.6 million, up from US$2,054.5 million, with net income of US$228.8 million versus US$146.1 million in fiscal 2018. The increase was driven largely by the Fermacell acquisition, completed on 3 April 2018 for a purchase price of €516.4 million, which added the Europe Building Products segment (net sales of US$368.3 million). Net income was helped by a favorable movement in asbestos adjustments, which were a US$22.0 million expense versus US$156.4 million in fiscal 2018, partly offset by higher SG&A (US$403.6 million, up 30%) and a product line discontinuation charge of US$29.5 million tied to the exit of the fiberglass windows business and the MCT product line. The balance sheet expanded significantly, with total assets of US$4,032.6 million versus US$2,351.0 million and total shareholders' equity of US$974.4 million, compared with a deficit of US$(221.5) million a year earlier. Net debt rose to US$1,301.6 million from US$602.8 million, reflecting the Fermacell financing. Net cash from operating activities was US$287.6 million, and cash used in investing activities was US$848.0 million, including the US$558.7 million acquisition. The company expects continued modest US housing market growth into fiscal 2020 and expects its Europe Building Products segment to deliver year-on-year net sales and operating income margin growth. The filing's key ongoing risk remains the asbestos liability under the AFFA, recorded at US$1,089.6 million gross and US$608.4 million net of tax, with annual payments to AICF of up to 35% of free cash flow. A payment of approximately US$100.9 million is anticipated on 1 July 2019. Other notable items include one customer accounting for greater than 10% of net sales each year, and the company's Irish domicile and US-Ireland treaty dependence.

    May 21, 2019
  10. 2018

    James Hardie Industries Annual Report, Year Ended Mar 31, 2018

    James Hardie Industries plc, filing its annual report on Form 20-F for the fiscal year ended 31 March 2018, reported net sales of $2,054.5 million, up from $1,921.6 million in fiscal 2017, with gross profit of $730.2 million. Net income fell to $146.1 million from $276.5 million, driven mainly by an unfavorable asbestos adjustment of $156.4 million (versus a $40.4 million benefit in fiscal 2017), a $26.1 million loss on early debt extinguishment, and $10.0 million of Fermacell acquisition costs. Diluted EPS was $0.33, compared with $0.62 a year earlier. Adjusted net income, a non-GAAP measure the company presents, was $291.3 million. North America Fiber Cement remained the largest segment, with net sales of $1,578.1 million and operating income of $381.9 million. International Fiber Cement reported net sales of $461.7 million and operating income of $108.4 million. Cash provided by operating activities was $295.0 million, and capital expenditures rose to $203.7 million, largely for the Tacoma greenfield expansion. Net debt increased to $602.8 million at 31 March 2018 from $485.6 million a year earlier. Subsequent to year end, on 3 April 2018, the company completed the acquisition of Fermacell for an enterprise value of €473.0 million, funded partly by a €400.0 million drawdown on a 364-day term loan. The company also issued US$800.0 million of senior notes in December 2017 and redeemed its 5.875% notes due 2023. Beginning in fiscal 2019, it plans to report a new European Building Products segment.

    May 22, 2018
  11. 2017

    James Hardie Industries Annual Report, Year Ended Mar 31, 2017

    James Hardie Industries plc filed its 2017 Annual Report on Form 20-F for the fiscal year ended 31 March 2017. Net sales rose to US$1,921.6 million from US$1,728.2 million, and net income increased to US$276.5 million (US$0.62 per diluted share) from US$244.4 million. The increase was driven by higher volumes in North America Fiber Cement and International Fiber Cement, a favorable movement in asbestos adjustments, and higher operating performance, partly offset by higher SG&A expenses. Gross margin was 35.1%, down 1.5 percentage points, as production and start-up costs rose in North America. North America Fiber Cement remained the core business, with net sales of US$1,493.4 million, operating income of US$343.9 million and a 23.0% operating margin. Gross margin in that segment fell 3.1 percentage points on unfavorable plant performance and higher freight costs. The company moved to a net debt position of US$485.6 million at 31 March 2017, and total shareholders' deficit was US$(212.2) million, reflecting the AFFA asbestos liability of US$1,159.7 million on the balance sheet. Cash flow from operations was US$292.1 million. Management plans an approximately US$102.2 million AICF contribution on 3 July 2017, and it announced a final dividend of 0.28 US cents per security. Key risks include the AFFA funding obligation (35% of free cash flow), the sensitivity of the asbestos liability to actuarial assumptions, Australian dollar exposure, and concentration of customer and distribution channels.

    May 18, 2017
  12. 2016

    James Hardie Industries Annual Report, Year Ended Mar 31, 2016

    James Hardie Industries plc filed its annual report on Form 20-F for the fiscal year ended 31 March 2016. Net sales rose to US$1,728.2 million from US$1,656.9 million, and net income fell to US$244.4 million from US$291.3 million, mainly reflecting higher income tax expense, higher interest expense and an unfavorable change in asbestos adjustments. Operating income was US$354.0 million. Adjusted net income, which excludes asbestos, New Zealand weathertightness claims, non-recurring stamp duty and other tax adjustments, was US$242.9 million. Net cash provided by operating activities increased to US$260.4 million from US$179.5 million. The North America and Europe Fiber Cement segment drove growth, with net sales of US$1,386.3 million and operating income of US$340.6 million, up 19% on higher volumes and lower production costs. The Asia Pacific Fiber Cement segment saw net sales decline to US$341.9 million from US$380.4 million, largely due to currency translation and the sale of the Australian Pipes business. The company reported a net debt position of US$405.7 million at 31 March 2016, and it cites an undiscounted, uninflated central estimate of the asbestos liability, net of insurance recoveries, of A$1.434 billion. The company also declared dividends of US$0.58 per share for the year and announced a US$100.0 million share buyback program for the twelve months through May 2017. The filing describes ongoing asbestos exposure through the Asbestos Injuries Compensation Fund (AICF), under which the company's annual payments are linked to 35% of free cash flow. The company anticipates a payment of approximately US$91.1 million to AICF on 1 July 2016. Management expects moderate growth in the US housing market in fiscal year 2017.

    May 19, 2016
  13. 2015

    James Hardie Industries Annual Report, Year Ended Mar 31, 2015

    James Hardie Industries plc filed its Form 20-F annual report for the fiscal year ended 31 March 2015. Net sales rose to US$1,656.9 million from US$1,493.8 million, and net income increased to US$291.3 million from US$99.5 million. Gross profit was US$578.8 million, with a gross margin of 34.9%. The result was helped by a favorable asbestos adjustment of US$33.4 million, which benefited from a US$144.7 million foreign exchange gain on the Australian dollar-denominated AFFA liability. Adjusted net income, excluding asbestos and other specified items, was US$221.4 million, up 12% from US$197.2 million. Operating cash flow fell to US$179.5 million from US$322.8 million, mainly because of a US$113.0 million payment to AICF. Capital expenditure rose to US$276.2 million from US$115.4 million, and the company moved to a net debt position of US$330.5 million at year end. The USA and Europe Fiber Cement segment drove growth, with net sales of US$1,276.5 million, volume of 1,849.7 million square feet and operating income of US$285.9 million. The Asia Pacific Fiber Cement segment reported net sales of US$380.4 million and operating income of US$94.1 million. Management expects moderate growth in the US housing market in fiscal 2016, and it highlighted the sale of the Australian concrete pipes business and the Blandon, Pennsylvania site as pending transactions expected to close in the first half of fiscal 2016. The main investor considerations are the continuing asbestos liability, recorded at US$1,421.6 million on an undiscounted and uninflated basis, and the sensitivity of that liability to Australian dollar movements and claims experience. The filing also notes a US$325.0 million senior unsecured notes issue due 2023, a dividend payout target of 50-70% of net income excluding asbestos, and a new share buyback program of up to 5% of issued capital.

    May 21, 2015
  14. 2014

    James Hardie Industries Annual Report, Year Ended Mar 31, 2014

    James Hardie Industries plc (formerly James Hardie Industries SE) reported net sales of US$1,493.8 million for the fiscal year ended 31 March 2014, up 13% from US$1,321.3 million in fiscal 2013. Operating income rose to US$53.1 million from US$29.5 million, after unfavourable asbestos adjustments of US$195.8 million. Net income increased to US$99.5 million from US$45.5 million, and diluted earnings per share were US$0.22 versus US$0.10. Net income excluding asbestos, asset impairments, ASIC expenses, New Zealand product liability and tax adjustments rose 40% to US$197.2 million. The USA and Europe Fibre Cement segment drove results, with net sales up 19% to US$1,127.6 million on 14% higher volume and a 4% higher average net sales price. Segment operating income increased 63% to US$237.0 million. Asia Pacific Fibre Cement net sales fell 1% to US$366.2 million in US dollars, though sales rose 9% in Australian dollars. Net cash provided by operating activities was US$322.8 million, capital expenditures were US$115.4 million, and dividends paid were US$199.1 million. Cash stood at US$167.5 million at year end, with US$355.0 million of undrawn credit facilities. The key risk for investors is the asbestos liability recorded for the AICF funding arrangement, which stood at US$1,706.2 million gross and a net unfunded AFFA liability of US$979.2 million net of tax at 31 March 2014. Shareholders' equity was a deficit of US$(199.0) million, and the company expects to contribute approximately US$113.0 million to AICF on 1 July 2014.

    Jun 26, 2014
  15. 2013

    James Hardie Industries Annual Report, Year Ended Mar 31, 2013

    James Hardie Industries plc, a fibre cement building products manufacturer, reported fiscal year 2013 (ended 31 March 2013) net sales of US$1,321.3 million, up from US$1,237.5 million, with the USA and Europe Fibre Cement segment contributing US$951.4 million and Asia Pacific Fibre Cement US$369.9 million. Operating income fell sharply to US$29.5 million from US$155.5 million, driven mainly by US$117.1 million of unfavourable asbestos adjustments, US$16.9 million of asset impairments and US$13.2 million of New Zealand product liability expenses. Net income declined to US$45.5 million (US$0.10 per diluted share) from US$604.3 million, which in the prior year included a US$485.2 million tax benefit from the ATO appeal. Net income excluding asbestos, impairments, ASIC expenses, New Zealand product liability and tax adjustments decreased 2% to US$140.8 million. The company ended the year with US$153.7 million in cash, no drawn debt against US$405.0 million of undrawn credit facilities, and shareholders' equity of US$18.2 million, down from US$126.4 million. Total dividends paid in fiscal 2013 were US$188.5 million, and the board declared a second-half ordinary dividend of US13.0 cents plus a special dividend of US24.0 cents per share, bringing the full-year dividend to US42.0 cents. The filing also notes that the company expects to spend approximately US$150 million on capital expenditures in fiscal 2014 and that the asbestos liability (AICF funding under the AFFA) of US$1,693.7 million remains the most significant long-term obligation, with a net unfunded AFFA liability, net of tax, of US$851.6 million. Looking ahead, management said US housing starts rose 27% to 565,900 in fiscal 2013 and expects a sustainable but protracted US recovery, anticipating a US Fibre Cement operating income margin above 20% in fiscal 2014 if demand and pricing improve. Investors should weigh this outlook against legacy exposures, including the New Zealand Ministry of Education representative action filed in April 2013, which the company says it cannot yet quantify.

    Jun 27, 2013
  16. 2012

    James Hardie Industries Annual Report, Year Ended Mar 31, 2012

    James Hardie Industries SE filed its Form 20-F annual report for the fiscal year ended 31 March 2012. Net sales rose to US$1,237.5 million from US$1,167.0 million, with USA and Europe Fibre Cement contributing US$862.0 million and Asia Pacific Fibre Cement US$375.5 million. Operating income increased to US$155.5 million from US$104.7 million, largely because asbestos adjustments were smaller (US$15.8 million unfavourable versus US$85.8 million), partly offset by a US$14.3 million impairment charge. Net income was US$604.3 million, boosted by a US$485.2 million income tax benefit from the favourable resolution of the ATO's 1999 disputed amended assessment. Excluding asbestos, impairments, ASIC expenses and tax adjustments, net income was US$140.4 million, up 20%. The balance sheet moved to a net cash position of US$265.4 million at 31 March 2012, compared with net debt of US$40.4 million a year earlier, and shareholders' equity turned positive at US$126.4 million from a deficit of US$454.5 million. Operating cash flow was US$387.2 million, including an ATO cash refund of US$396.3 million, and the company made an early US$138.7 million contribution to the Asbestos Injuries Compensation Fund (AICF). The asbestos liability remains large at US$1,662.6 million, and the company continues to carry exposure to ASIC proceedings, currency movements between the US and Australian dollars, and a concentrated customer base. Management expects the US housing market to improve only slightly over the prior year, with Australian residential construction expected to contract and New Zealand to stay subdued. The board declared a final dividend of US38.0 cents per share, bringing the full-year dividend to US42.0 cents, and approved a new share buyback of up to 5% of issued capital. Planned fiscal 2013 capital expenditure is between US$70 million and US$100 million.

    Jul 2, 2012
  17. 2011-A

    James Hardie Industries Annual Report (Amendment), Year Ended Mar 31, 2011

    James Hardie Industries SE filed this Amendment No. 1 to its Annual Report on Form 20-F for the fiscal year ended 31 March 2011, dated 14 July 2011. The amendment corrects the "Total Value at Grant (US$)" and "Vested" columns in two remuneration report tables, section 5.2(a) Options and section 5.2(b) RSUs, on pages 54 and 55 of the annual report. It does not change any other part of the annual report. The corrected tables set out equity holdings for senior executives, including Louis Gries, Russell Chenu, Robert Cox, Mark Fisher and Nigel Rigby, for the years ended 31 March 2011 and 2010. They show options and deferred bonus, relative TSR and hybrid RSUs by grant date, with holdings at 1 April 2010, grants, vesting, exercise and lapse during the year, and holdings at 31 March 2011. Per-right fair values are estimated at grant using the Black-Scholes or Monte Carlo option pricing methods, depending on the plan. The filing also lists certifications under Section 302 of the Sarbanes-Oxley Act by the Chief Executive Officer and Chief Financial Officer, and a Section 906 certification by both officers. Louis Gries signed the filing as Chief Executive Officer.

    Jul 14, 2011
  18. 2011

    James Hardie Industries Annual Report, Year Ended Mar 31, 2011

    James Hardie Industries SE (JHX) filed its annual report on Form 20-F for the fiscal year ended 31 March 2011. Net sales were US$1,167.0 million, up from US$1,124.6 million, but the company reported a net loss of US$347.0 million (US$(0.80) per share), compared with a net loss of US$84.9 million in fiscal 2010. The loss was driven mainly by a non-cash US$345.2 million tax charge after the Federal Court dismissed RCI's appeal of the 1999 ATO amended assessment, a US$32.6 million tax charge tied to the corporate structure simplification, and unfavourable asbestos adjustments of US$85.8 million. Operating income was US$104.7 million, compared with an operating loss of US$21.0 million a year earlier. Excluding asbestos, ASIC and tax adjustments, net income fell 12% to US$116.7 million. USA and Europe Fibre Cement net sales declined 2% to US$814.0 million on a 4% drop in volume, while operating income for that segment fell 23% to US$160.3 million, mainly due to higher pulp and freight costs. Asia Pacific Fibre Cement net sales rose 19% to US$353.0 million. Net debt fell to US$40.4 million from US$134.8 million, and total credit facilities were US$320.0 million with US$59.0 million drawn. The company announced a capital management policy to distribute 20% to 30% of after-tax profits, excluding asbestos adjustments, as ordinary dividends, plus an on-market buy-back of up to 5% of issued capital. The asbestos liability stood at US$1,698.1 million at 31 March 2011, and the filing states that the AICF contribution due in July 2011 is US$51.5 million.

    Jun 29, 2011
  19. 2010

    James Hardie Industries Annual Report, Year Ended Mar 31, 2010

    James Hardie Industries SE (JHX) filed its annual report on Form 20-F for fiscal year ended March 31, 2010. Net sales fell to $1,124.6 million from $1,202.6 million, while the company reported an operating loss of $21.0 million, driven primarily by $224.2 million of unfavorable asbestos adjustments, largely caused by the Australian dollar's appreciation against the U.S. dollar. Net loss was $84.9 million versus net income of $136.3 million in fiscal 2009. Excluding asbestos, ASIC expenses and tax adjustments, net income rose to $133.0 million from $100.5 million. Operating cash flow was $183.1 million, compared with an outflow of $45.2 million the prior year, and total debt declined to $154.0 million from $324.0 million. Shareholders' deficit was $(117.9) million. The company completed its re-domicile from The Netherlands to Ireland, with Stage 2 approved June 2, 2010 and the company becoming subject to Irish law on June 17, 2010 and an Irish tax resident on June 29, 2010. The principal ongoing risk is the Amended Final Funding Agreement with the Asbestos Injuries Compensation Fund (AICF), for which the company recorded an asbestos liability of $1.6 billion; the company expects a further contribution of $63.7 million in fiscal 2011. Other open matters include ASIC proceedings against the company, with appeals pending and no loss reserve recorded, and an ATO dispute over a A$184.0 million amended assessment, for which a A$269.9 million deposit has been made. For fiscal 2011, the company expects capital expenditures of approximately $70 million to $80 million and states that operating costs are expected to be considerably higher, while U.S. housing starts remain depressed, with a 531,000 seasonally adjusted annual rate in March 2010.

    Jun 30, 2010
  20. 2009

    James Hardie Industries Annual Report, Year Ended Mar 31, 2009

    James Hardie Industries N.V. (JHX) filed this annual report on Form 20-F for the fiscal year ended March 31, 2009. Net sales fell 18% to $1,202.6 million, while operating income swung to $173.6 million from an operating loss of $36.6 million in fiscal 2008, which had been hit by $240.1 million of unfavorable asbestos adjustments. Net income was $136.3 million, or $0.31 per diluted share, compared with a net loss of $71.6 million in fiscal 2008. The result was helped by a $17.4 million favorable net asbestos adjustment and a $179.7 million favorable foreign exchange effect on the Australian-dollar-denominated asbestos liability. The balance sheet remains weak. Total shareholders' deficit was $(108.7) million, the asbestos liability was $1,284.5 million, and total debt was $324.0 million against cash of $42.4 million. Operating cash flow was negative at $(45.2) million, reflecting an $101.6 million ATO settlement payment and $110.0 million of quarterly AICF installments. Dividends were suspended for the remainder of the year. The filing also describes a two-stage proposal to move the company's domicile, first to a European Company (SE) in the Netherlands and then to Ireland, which requires separate shareholder votes. Key open risks include the ASIC civil judgment against the company, the Chile damages award of $13.4 million under appeal, the ATO appeal on the RCI 1999 assessment, and the annual IRS treaty-eligibility question for 2008 and later years.

    Jun 25, 2009
  21. 2008

    James Hardie Industries Annual Report, Year Ended Mar 31, 2008

    James Hardie Industries N.V. (now James Hardie Industries) filed this Form 20-F annual report for the fiscal year ended March 31, 2008. Net sales fell 5% to $1,468.8 million, from $1,542.9 million in fiscal 2007, driven by lower USA Fiber Cement volume. The company reported an operating loss of $36.6 million and a net loss of $71.6 million, compared with net income of $151.7 million in fiscal 2007. The results were driven mainly by $240.1 million of asbestos adjustments, which include a $87.2 million foreign exchange effect, and $71.0 million of impairment charges. Shareholders' equity moved to a deficit of $202.6 million, from $258.7 million a year earlier. Total debt rose to $264.5 million, and cash and cash equivalents were $35.4 million at year-end. The filing is dominated by legal and tax exposures. The company recorded an asbestos liability of $1.6 billion under the Amended Final Funding Agreement with the Asbestos Injuries Compensation Fund. ASIC civil proceedings against the company and former officers remain unresolved, with no reserve recorded. The IRS issued a Notice of Proposed Adjustment on June 23, 2008. If upheld, the company estimates about $37.0 million of additional tax for 2006 and 2007, plus interest and penalties. The ATO is also pursuing a A$368.0 million amended assessment against RCI Pty Ltd, of which the company has paid 50% as a deposit and has not recorded a liability. Operationally, the USA Fiber Cement segment remained the largest contributor, at 78% of net sales. Its volume fell 11%, while the average net sales price rose 2%. Management expects further weakness in new housing construction in the short term. The company also announced the closure of its Plant City, Florida pipe plant and the suspension of production at its Blandon, Pennsylvania plant. Capital expenditures were $38.5 million, and the company repurchased shares for $208.0 million.

    Jul 8, 2008
  22. 2007-A

    James Hardie Industries Annual Report (Amendment), Year Ended Mar 31, 2007

    This Form 20-F/A No. 2 is Amendment No. 2 to the Annual Report of James Hardie Industries N.V. (now James Hardie Industries) for the fiscal year ended March 31, 2007, filed September 18, 2007. The filing itself does not contain the company's full financial statements or operating results. Its stated purpose is to furnish an amended Exhibit 4.28, an Agreement for the Extraction and Sale of Silica dated November 1, 2002 between Riverside Cement Company and Victorville Industrial Minerals, Inc. Following correspondence with the SEC, the company now discloses the counterparty's name, which had previously been omitted under a confidential treatment request filed separately with the SEC. The cover page reports 467,295,391 shares of common stock outstanding at March 31, 2007. The registrant is identified as a large accelerated filer and a well-known seasoned issuer, and it elected to follow Item 18 financial statement reporting. The company's common stock is represented by CHESS Units of Foreign Securities, and American Depositary Shares, each representing five CHESS Units, are listed on the New York Stock Exchange. The filing is signed by Louis Gries, Chief Executive Officer, and includes Section 302 certifications from the CEO and CFO as Exhibits 12.1 and 12.2. For investors, this amendment is a narrow disclosure update. It contains no new financial results, guidance, or operating commentary. The principal new information is the identity of the counterparty to the silica extraction and sale agreement.

    Sep 18, 2007
  23. 2007-A

    James Hardie Industries Annual Report (Amendment), Year Ended Mar 31, 2007

    This Amendment No. 1 to the Form 20-F for James Hardie Industries N.V. covers the fiscal year ended March 31, 2007. It amends Item 16C, Principal Accountant Fees and Services, to correct the fees paid to the independent registered public accounting firm for that year. The amendment was dated August 7, 2007 and signed by Chief Executive Officer Louis Gries. The registrant reported 467,295,391 shares of common stock outstanding at March 31, 2007, and checked the boxes for well-known seasoned issuer and large accelerated filer. The corrected fee disclosure covers fiscal years 2007, 2006 and 2005. Audit fees were $2.1 million in fiscal 2007, $1.6 million in fiscal 2006 and $3.1 million in fiscal 2005. Audit-related fees were $0.1 million, $0.1 million and $0.2 million for the same years. Tax fees were $8.0 million in fiscal 2007, $5.2 million in fiscal 2006 and $4.2 million in fiscal 2005. Fiscal 2007 audit fees include $0.8 million for Sarbanes-Oxley compliance testing, and fiscal 2005 audit fees include $1.9 million for internal investigation work. The filing states that PricewaterhouseCoopers LLP services are pre-approved annually by the Audit Committee under its policy and legal requirements, and that all pre-approved services are permissible under the SEC's auditor independence rules. The exhibit index lists Section 302 certifications from the CEO and CFO and a Section 906 certification.

    Aug 7, 2007
  24. 2007

    James Hardie Industries Annual Report, Year Ended Mar 31, 2007

    James Hardie Industries N.V. (JHX) reported fiscal year 2007 (ended March 31, 2007) total net sales of $1,542.9 million, up from $1,488.5 million, with USA Fiber Cement contributing $1,262.3 million. The company recorded an operating loss of $86.6 million, compared with an operating loss of $434.9 million in fiscal 2006, because of asbestos adjustments of $405.5 million in fiscal 2007 and a $715.6 million asbestos provision in fiscal 2006. Income from continuing operations was $150.8 million, and net income was $151.7 million ($0.33 per diluted share), helped by a $335.0 million tax benefit tied to implementation of the Final Funding Agreement with the Asbestos Injuries Compensation Fund. The filing shows that the company's asbestos liability is now substantially defined. The net Final Funding Agreement liability was $786.1 million at March 31, 2007, and cash flow from operations was negative $67.1 million, reflecting an ATO deposit payment of $154.8 million and an initial AICF funding payment of $148.7 million. Cash and cash equivalents were $34.1 million, against $188.0 million of drawn credit facilities, and net debt was $153.9 million. Significant risks remain. The company faces an ongoing ASIC civil proceeding against the company and ten former officers and directors, a disputed A$368.0 million ($296.9 million) ATO amended assessment on which the company has paid half and guaranteed the rest, and foreign exchange exposure because asbestos payments are denominated in Australian dollars. The company also reported that U.S. housing starts fell and that it expects weak market conditions to continue into fiscal 2008.

    Jul 6, 2007
  25. 2006

    James Hardie Industries Annual Report, Year Ended Mar 31, 2006

    James Hardie Industries N.V. (now James Hardie Industries) reported a fiscal 2006 net loss from continuing operations of $506.7 million, compared with income of $127.9 million in fiscal 2005, driven primarily by a $715.6 million asbestos provision recorded as of March 31, 2006. Net sales rose 23% to $1,488.5 million, with USA Fiber Cement contributing $1,218.4 million (up 30%). Operating loss was $434.9 million versus operating income of $196.2 million a year earlier. The provision reflects the Final Funding Agreement with the NSW Government, which is subject to unmet conditions precedent, principally tax-exempt status for the special purpose fund (SPF) and approval by lenders and shareholders. The Australian Taxation Office has refused to endorse the SPF as a tax concession charity, and an amended assessment of A$378.0 million ($284.6 million) against RCI Pty Ltd is under appeal; the company paid 50% (A$189.0 million) in July 2006 and guaranteed the rest. The company's underlying fiber cement business remained strong, with USA Fiber Cement operating income up 42% to $342.6 million and total volume growth in the U.S. The filing also flags material risks for investors: the initial SPF payment of approximately A$154 million, the annual payment obligations, currency exposure because asbestos payments are denominated in Australian dollars while results are reported in U.S. dollars, and no forward exchange contracts in place at March 31, 2006. Cash and cash equivalents were $315.1 million at year-end, with $302.7 million of credit facilities drawn, and shareholders' equity fell to $94.9 million from $624.7 million.

    Sep 29, 2006
  26. 2005

    James Hardie Industries Annual Report, Year Ended Mar 31, 2005

    James Hardie Industries N.V. reported net sales of $1,210.4 million for fiscal year ended March 31, 2005, up 23% from $981.9 million, with operating income of $196.2 million (up 14%) and income from continuing operations of $127.9 million (up 2%). USA Fiber Cement generated $939.2 million of net sales, about 78% of the total, and was the primary contributor to operating income. Net income was $126.9 million, or $0.28 per diluted share. The filing's dominant issue is asbestos liability arising from former subsidiaries Amaca, Amaba and ABN 60, following a New South Wales Special Commission of Inquiry (SCI) report that found a significant funding shortfall. The Company signed a non-binding Heads of Agreement in December 2004 to fund a special purpose fund, but the Principal Agreement is not yet executed, and the Company has recorded no provision because the liability is not yet probable and estimable. SCI and related expenses were $28.1 million in fiscal 2005 and are expected to remain material in the short term. The filing also notes that the NSW Government has said it may pass retroactive legislation if negotiations fail, and that an ASIC investigation is ongoing. Other matters include leadership turnover (new CEO Louis Gries and CFO Russell Chenu appointed in February 2005), a new $355 million unsecured debt facility entered in June 2005, a 40% increase in capital expenditures to $153.0 million including a new plant in Pulaski, Virginia, and a U.S.-Netherlands tax treaty amendment that could raise the effective tax rate if the Company cannot satisfy new requirements.

    Jul 7, 2005
  27. 2004

    James Hardie Industries Annual Report, Year Ended Mar 31, 2004

    James Hardie Industries N.V. (filed as James Hardie Industries N.V.) reported fiscal year 2004 (ended March 31, 2004) net sales of $981.9 million, up 25% from $783.6 million, with operating income up 34% to $172.2 million and income from continuing operations up 50% to $125.3 million. Net income was $129.6 million, versus $170.5 million in fiscal 2003, which included large gains on divestitures. USA Fiber Cement generated $738.6 million of net sales, about 75% of the total, and was the primary contributor to operating income. Cash flow from operating activities rose to $162.6 million from $64.8 million, and capital expenditures were $74.1 million. The filing is dominated by risk tied to asbestos liabilities of former subsidiaries Amaca, Amaba and ABN 60. A New South Wales Special Commission of Inquiry reported on September 21, 2004 that a significant funding shortfall existed, with a discounted central estimate of approximately A$1.570 billion in liabilities. The Company's updated actuarial study put the discounted central estimate at A$1.536 billion. The Company has not recorded a provision for asbestos liabilities because it considers a provision not probable or estimable at this time. The NSW Government has said it may pass legislation that would alter the Company's liability position, and the Company is in negotiations with asbestos claimant representatives. Management also disclosed interim executive changes, including the resignations of the CEO and CFO in October 2004, and an ongoing ASIC investigation. For investors, the key issues are the outcome of the asbestos negotiations, the potential for a substantial future provision or negative shareholders' equity that could restrict dividends, and possible debt covenant consequences. Management also flagged a possible loss of U.S.-Netherlands treaty benefits that could raise the effective tax rate from fiscal 2006.

    Nov 22, 2004
  28. 2003

    James Hardie Industries Annual Report, Year Ended Mar 31, 2003

    James Hardie Industries N.V. (filed as Hardie James Industries) reported fiscal 2003 (year ended March 31, 2003) total net sales of $803.7 million, up from $606.9 million, with USA Fiber Cement contributing $599.7 million and Asia Pacific Fiber Cement $194.4 million. Operating profit rose to $131.6 million from $48.3 million, and income from continuing operations was $85.4 million versus $28.3 million. Net income was $170.5 million, or $0.37 per diluted share, including $85.1 million from discontinued operations, primarily the April 2002 sale of the Gypsum business for $345.0 million in cash and the March 2003 sale of the Las Vegas gypsum mine. The company describes itself as the largest manufacturer of fiber cement products in the United States, Australia, New Zealand and the Philippines. Its U.S. fiber cement volume rose to 1,273.6 million square feet from 988.5 million, and the average U.S. selling price increased to $471 per thousand square feet from $450. Long-term debt fell to $165.0 million from $325.0 million, and shareholders' equity rose to $434.7 million from $370.7 million. Cash flow from operations was $64.8 million, down from $76.6 million, and capital expenditures were $90.2 million. The filing also highlights risks investors should weigh: exposure to residential construction cycles, a Dutch finance subsidiary tax regime that the EU has ordered ended by December 31, 2010, and continuing indemnification obligations tied to asbestos claims involving former subsidiaries. The company transferred control of ABN 60 to the ABN 60 Foundation on March 31, 2003, and states that it does not believe it will have liability for the former subsidiaries' asbestos obligations.

    Jul 2, 2003
  29. 2002

    James Hardie Industries Annual Report, Year Ended Mar 31, 2002

    Sep 9, 2002